Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances and strategies in BET bromodomain inhibition for drug discovery. | Eur J Med Chem | 2026 | 41056820 | PubTator, text mining | PubMed |
| Correlation of antimicrobial peptide Human β Defensin-2 with clue cell appearance and the type of culture isolate in women with spontaneous and recurrent pregnancy losses. | J Immunoassay Immunochem | 2026 | 40836758 | PubTator, text mining | PubMed |
| Transcriptomic profiling reveals distinct molecular signatures among lesion types in hidradenitis suppurativa. | Front Immunol | 2025 | 41766817 | PubTator, text mining | PubMed |
| A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial. | BMC Gastroenterol | 2025 | 41436948 | PubTator, text mining | PubMed |
| The Role of Pan-Cytokeratin In Tumor Budding Upgrading In Malignant Colorectal Polyps At Stage pT1. | Cancer Manag Res | 2025 | 41403817 | PubTator, text mining | PubMed |
| Correction: Human breast milk-derived Limosilactobacillus fermentum strains modulate hBD-2 expression against Neisseria meningitidis infection through the TLR-2/p38-MAPK/NF-κB pathway. | World J Microbiol Biotechnol | 2025 | 41369887 | PubTator, text mining | PubMed |
| Pathological and Clinical Significance of Tumor Budding and Its Association with Epithelial-Mesenchymal Transition in Colorectal Carcinoma: A Retrospective Observational Study. | Iran J Med Sci | 2025 | 41262322 | PubTator, text mining | PubMed |
| Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease. | Drug Discov Today | 2025 | 41241376 | PubTator, text mining | PubMed |
| DEFB4A/hBD2, a non-invasive serum biomarker for detection of ulcerative colitis. | Sci Rep | 2025 | 41198907 | PubTator, text mining | PubMed |
| Influence of DEFB4 copy number variants on gene expression in monocytes. | BMC Res Notes | 2025 | 41146334 | PubTator, text mining | PubMed |
| Comprehensive analysis of transcriptome and pathway interactions in periodontitis. | J Appl Oral Sci | 2025 | 41124422 | PubTator, text mining | PubMed |
| Polybromo‑1 Bromodomain Inhibitor Selectivity Is Mediated by a Unique Ligand-Binding Pocket. | ACS Med Chem Lett | 2025 | 41089488 | PubTator, text mining | PubMed |
| Exploring the Selective Potential Inhibitors for Homologous Protein BD1/BD2 with MD and AIDD Methods. | Curr Comput Aided Drug Des | 2025 | 41036750 | PubTator, text mining | PubMed |
| The Role of Visfatin/NAMPT in the Pathogenesis of Psoriasis. | Metabolites | 2025 | 41002974 | PubTator, text mining | PubMed |
| Structure-Antimicrobial Activity Relationships of Recombinant Host Defence Peptides Against Drug-Resistant Bacteria. | Microb Biotechnol | 2025 | 40985079 | PubTator, text mining | PubMed |
| The Ongoing Struggle to Find a Gold Standard for PJI Diagnosis. | Reports (MDPI) | 2025 | 40981112 | PubTator, text mining | PubMed |
| Can Faecal Eosinophil Cationic Protein and β-Defensin-2 Levels Be Useful in the Diagnosis and Follow-Up of Infants with Milk-Protein-Induced Allergic Proctocolitis? | Nutrients | 2025 | 40944185 | PubTator, text mining | PubMed |
| Identification and biological evaluation of novel indole-2-one derivatives as BRD4-BD2 inhibitors. | Bioorg Med Chem | 2025 | 40929782 | PubTator, text mining | PubMed |
| Machine learning-based identification of a transcriptomic blood signature discriminating between systemic autoimmunity and infection. | Med | 2025 | 40914170 | PubTator, text mining | PubMed |
| Rational design of a multi epitope vaccine against Salmonella typhi via subtractive proteomics, reverse vaccinology and molecular modeling. | Sci Rep | 2025 | 40890251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=4